Amgen (AMGN) Tops Q4 EPS by 10c, Offers FY Guidance
Tweet
Share
E-mail
Get Alerts AMGN Hot Sheet
Price: $438.03 -0.02%
EPS Growth %: +2.7%
Financial Fact:
Research and development: 990M
Today's EPS Names:
RCBC, GASS, YSG, More
EPS Growth %: +2.7%
Financial Fact:
Research and development: 990M
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q4 EPS of $2.89, $0.10 better than the analyst estimate of $2.79. Revenue for the quarter came in at $5.97 billion versus the consensus estimate of $5.74 billion.
GUIDANCE:
Amgen sees FY2017 EPS of $11.80-$12.60, versus the consensus of $12.44. Amgen sees FY2017 revenue of $22.3-23.1 billion, versus the consensus of $23.3 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance
- Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
- Goldman Sachs favors equities over credit as late-cycle risks build
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
